title: Expression of estrogen receptors alpha and beta in human osteoblasts: identification of exon-2 deletion variant of estrogen receptor beta in postmenopausal women.
abstract: BACKGROUND
  Postmenopausal osteoporosis is associated with estrogen deficiency. Estrogens have effects on bone metabolism, which are mediated by estrogen receptors (ERs). If estrogen responsiveness is related to the ER expression level, ER expression in postmenopausal women should be different from previous studies using osteoblast lineage. We investigated the expression of variant isoforms of ER messenger ribonucleic acid (mRNA) in osteoblasts (OB) from postmenopausal women and a human osteosarcoma cell line, MG 63.
  
  
  METHODS
  Osteoblast cultures were prepared from the upper femur of postmenopausal patients or MG 63. For OB cultures at 5, 10, 15, 20, and 25 days, the expressions of ERalpha and beta mRNA were examined using reverse transcriptase-polymerase chain reaction.
  
  
  RESULTS
  In MG 63, ERbeta mRNA was constantly and highly expressed during the 25-day culture, whereas ERalpha mRNA was barely detected. In the primary OB cells, both ERalpha and beta mRNA were transcribed during the 25-day culture, but expression of ERalpha mRNA was much stronger than that of ERbeta mRNA. A splice variant form of ERbeta mRNA that was missing the entire exon 2 (ERbeta delta 2) was detected and heterogeneously expressed in OB cultures from 16 postmenopausal women.
  
  
  CONCLUSIONS
  Differential expressions of these ER isoforms suggest that they may have different functions or that they interact with each other during bone metabolism. The different ratio of ERbeta to ERbeta delta 2 mRNA or ERalpha to ERbeta mRNA expressions in osteoblast cultures may be related to different bone conditions. Whether the presence of ERbeta delta 2 in postmenopausal women influences the biological properties of bone needs to be determined.
authors.affiliation: Department of Obstetrics and Gynecology, Chang Gung Memorial Hospital, Keelung, Taiwan 204, ROC. fangping@cgmh.org.tw
authors.forename: Fang-Ping
authors.initials: FP
authors.lastname: Chen
authors.forename: Todd
authors.initials: T
authors.lastname: Hsu
authors.forename: Chin-Hwa
authors.initials: CH
authors.lastname: Hu
authors.forename: Wen-Der
authors.initials: WD
authors.lastname: Wang
authors.forename: Kun-Chuang
authors.initials: KC
authors.lastname: Wang
authors.forename: Li-Fen
authors.initials: LF
authors.lastname: Teng
mesh_terms: D001859:Bone Neoplasms / Q000378:metabolism; D045744:Cell Line, Tumor; D047628:Estrogen Receptor alpha; D047629:Estrogen Receptor beta; D005091:Exons / Q000235:genetics*; D005260:Female; D017353:Gene Deletion; D006801:Humans; D010006:Osteoblasts / Q000737:chemistry*; D012516:Osteosarcoma / Q000378:metabolism; D017698:Postmenopause / Q000502:physiology*; D012333:RNA, Messenger / Q000032:analysis; D011960:Receptors, Estrogen / Q000235:genetics*
chemical_list: D047628:Estrogen Receptor alpha; D047629:Estrogen Receptor beta; D012333:RNA, Messenger; D011960:Receptors, Estrogen